Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 17, 2016

Primary Completion Date

January 29, 2018

Study Completion Date

January 29, 2018

Conditions
Parkinson Disease
Interventions
DRUG

Placebo

DRUG

PF-06649751

Trial Locations (37)

23456

Sentara Neurology Specialists, Virginia Beach

28806

Asheville Neurology Specialists PA, Asheville

30331

Atlanta Center for Medical Research, Atlanta

33136

University of Miami, Miami

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33612

University of South Florida Carol and Frank Morsani Center for Advanced Health Care, Tampa

University of South Florida Faculty Office Building, Tampa

University of South Florida, Tampa

33613

University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa

34128

Paracelsus-Elena-Klinik Kassel, Kassel

35043

Universitätsklinikum Gießen und Marburg GmbH, Marburg

38043

CHU de Grenoble Alpes, Grenoble

38700

CHU Grenoble Alpes, La Tronche

43614

University of Toledo, Gardner-McMaster Parkinson Center, Toledo

University of Toledo, Toledo

44195

Cleveland Clinic, Cleveland

44791

St. Josef Hospital GmbH, Bochum

58100

Edith Wolfson Medical Center, Holon

Pharmacy, Edith Wolfson Medical Center, Holon

60612

Rush University Medical Center, Chicago

66160

University of Kansas Medical Center, Kansas City

72076

University hospital Tuebingen, Tübingen

75013

Hopital Pitie Salpetriere, Paris

75401

AS Clinical Research Consultants of North Texas, PLLC, Greenville

77030

Baylor College of Medicine, Houston

83527

Klinik Haag i. OB, Haag I. OB

85013

St Joseph's Hospital and Medical Center, Barrow Neurology Clinics, Phoenix

St. Joseph's Hospital and Medical Center, Phoenix

89081

Universitaetsklinik Ulm, Ulm

94010

Hopital Henri Mondor, Créteil

Hôpital Henri Mondor, Créteil

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

13385 Cedex 05

Hospital de La Timone, Marseille

13385 cedex 05

Hospital La Timone, Marseille

75651 cedex 13

Hopital Pitie-Salpetriere, Paris

07551

Praxis Oehlwein Outpatient clinic for PD, DBS, Movement Disorders, Gera

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02847650 - Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease | Biotech Hunter | Biotech Hunter